Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics ...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing ...
A single regulator for construction is among a raft of measures announced today (26 February) in response to the Grenfell ...
ReSPECT- LM Phase 1 single dose is now complete, and the recommended Phase 2 dose (RP2D) for single administration therapy ...
Eikon Therapeutics, Inc., a pivotal-stage biotechnology company that integrates advanced engineering with cutting-edge ...
Good morning, and welcome to Tarsus Year End 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to David Nakasone, ...
Monroe Biomedical Research (MBR), a dedicated clinical trial site, is growing its footprint to enhance early-phase clinical ...
Kiniksa plans to initiate a Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis in mid-2025 –– KPL-387 Phase 1 single ascending dose ...
Belle Farm s first phase begins in Middleton, featuring 150 eco friendly homes with geothermal energy, solar power, and a ...
Following a public hearing Tuesday, the Weber County Commission officially approved proposed rezoning for Phase 6 of the ...
Branch circuits account for most circuits run in any electrical installation, so it pays to be familiar with the requirements ...
The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following ...